ow Vs High Dose Prednisolone In CRPS
Phase 3
Completed
- Conditions
- Health Condition 1: G890- Central pain syndrome
- Registration Number
- CTRI/2019/12/022237
- Lead Sponsor
- Prinicipal Investigator
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
The patients with CRPS I of shoulder joint attending neurology service will be included. A diagnosis of CRPS-I will be based on the following features
1. Pain and tenderness during humeral abduction, flexion, and external rotation.
2. Pain and dorsal swelling over the carpal bones.
3. Moderate fusiform edema of metacarpo-phalangeal and inter-phalangeal joints.
4. Change in temperature, color, and dryness of skin.
5. Loss of dorsal skin lines and change in nails
Exclusion Criteria
Patients with uncontrolled hypertension, diabetes, infection, organ failure, malignancy, shoulder joint dislocation or infection, children ( <18yrs), pregnancy and unwilling for consent will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method More than 50% improvements in VAS scoreTimepoint: 1 and 3 months
- Secondary Outcome Measures
Name Time Method Improvement in CRPS score, disability score and sleep quality by Daily sleep Interference Scale (DSIS) <br/ ><br>Change in pro and anti-inflammatory cytokine levels <br/ ><br>Side effects <br/ ><br>Timepoint: 1 and 3 months